Cargando…
Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy
Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and has the second highest mortality rate globally. Thanks to the advent of next-generation sequencing technologies, several novel candidate genes have been proposed for CRC susceptibility. Germline biallelic mutations in one or...
Autores principales: | Parsa, Fatemeh Ghorbani, Nobili, Stefania, Karimpour, Mina, Aghdaei, Hamid Asadzadeh, Nazemalhosseini-Mojarad, Ehsan, Mini, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950345/ https://www.ncbi.nlm.nih.gov/pubmed/35330396 http://dx.doi.org/10.3390/jpm12030396 |
Ejemplares similares
-
Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management
por: Rejali, Leili, et al.
Publicado: (2023) -
Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer
por: Pezeshkian, Zahra, et al.
Publicado: (2021) -
Increased Expression of VANGL1 Is Predictive of Lymph Node Metastasis in Colorectal Cancer: Results from a 20-Gene Expression Signature
por: Peyravian, Noshad, et al.
Publicado: (2021) -
Coexistence of KRAS and BRAF Mutations in Colorectal
Cancer: A Case Report Supporting The Concept of
Tumoral Heterogeneity
por: Larki, Pegah, et al.
Publicado: (2017) -
The CpG island methylator phenotype (CIMP) in colorectal cancer
por: Mojarad, Ehsan Nazemalhosseini, et al.
Publicado: (2013)